|
2017 Journal Article Risk predictors and causes of technique failure within the first year of peritoneal dialysis: An Australia and New Zealand dialysis and transplant registry (ANZDATA) studySee, Emily J., Johnson, David W., Hawley, Carmel M., Pascoe, Elaine M., Badve, Sunil V., Boudville, Neil, Clayton, Philip A., Sud, Kamal, Polkinghorne, Kevan R., Borlace, Monique and Cho, Yeoungjee (2017). Risk predictors and causes of technique failure within the first year of peritoneal dialysis: An Australia and New Zealand dialysis and transplant registry (ANZDATA) study. American Journal of Kidney Diseases, 72 (2), 188-197. doi: 10.1053/j.ajkd.2017.10.019 |
|
2017 Journal Article The SIESTA Trial: a randomized study investigating the efficacy, safety, and tolerability of acupressure versus sham therapy for improving sleep quality in patients with end-stage kidney disease on hemodialysisShen, Kunyu, Cho, Yeoungjee, Pascoe, Elaine M., Hawley, Carmel M., Oliver, Veronica, Hughes, Kathryn M., Baer, Richard, Frazier, Jeremy, Jarvis, Elizabeth, Tan, Ken-Soon, Liu, Xusheng, Gobe, Glenda and Johnson, David W. (2017). The SIESTA Trial: a randomized study investigating the efficacy, safety, and tolerability of acupressure versus sham therapy for improving sleep quality in patients with end-stage kidney disease on hemodialysis. Evidence-Based Complementary and Alternative Medicine, 2017 (1) 7570352, 7570352-10. doi: 10.1155/2017/7570352 |
|
2016 Journal Article An update on bone imaging and markers in chronic kidney diseaseKrishnasamy, Rathika, Hawley, Carmel M. and Johnson, David W. (2016). An update on bone imaging and markers in chronic kidney disease. Expert Review of Endocrinology and Metabolism, 11 (6), 455-466. doi: 10.1080/17446651.2016.1239527 |
|
2016 Journal Article Phosphate-binding agents in adults with CKD: a network meta-analysis of randomized trialsPalmer, Suetonia C., Gardner, Sharon, Tonelli, Marcello, Mavridis, Dimitris, Johnson, David W., Craig, Jonathan C., French, Richard, Ruospo, Marinella and Strippoli, Giovanni F. M. (2016). Phosphate-binding agents in adults with CKD: a network meta-analysis of randomized trials. American Journal of Kidney Diseases, 68 (5), 691-702. doi: 10.1053/j.ajkd.2016.05.015 |
|
2016 Journal Article Duration of hemodialysis following peritoneal dialysis cessation in Australia and New Zealand: proposal for a standardized definition of technique failureLan, Patrick G., Clayton, Philip A., Johnson, David W., McDonald, Stephen P., Borlace, Monique, Badve, Sunil V., Sud, Kamal and Boudville, Neil (2016). Duration of hemodialysis following peritoneal dialysis cessation in Australia and New Zealand: proposal for a standardized definition of technique failure. Peritoneal Dialysis International, 36 (6), 623-630. doi: 10.3747/pdi.2015.00218 |
|
2016 Journal Article Temporal changes in deceased kidney donor characteristics in AustraliaChan, Samuel, Campbell, Scott B., Clayton, Phillip A., Mudge, David W., Cho, Yeoungjee, Hawley, Carmel M., Johnson, David W. and Francis, Ross S. (2016). Temporal changes in deceased kidney donor characteristics in Australia. Transplantation Direct, 2 (11), 1-6. doi: 10.1097/txd.0000000000000624 |
|
2016 Journal Article The current state of peritoneal dialysisMehrotra, Rajnish, Devuyst, Olivier, Davies, Simon J. and Johnson, David W. (2016). The current state of peritoneal dialysis. Journal of the American Society of Nephrology, 27 (11), 3238-3252. doi: 10.1681/ASN.2016010112 |
|
2016 Journal Article Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipientsBadve, Sunil V., Pascoe, Elaine M., Burke, Michael, Clayton, Philip A., Campbell, Scott B., Hawley, Carmel M., Lim, Wai H., McDonald, Stephen P., Wong, Germaine and Johnson, David W. (2016). Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients. Clinical Journal of the American Society of Nephrology, 11 (10), 1845-1855. doi: 10.2215/CJN.00190116 |
|
2016 Journal Article Patterns of oral disease in adults with chronic kidney disease treated with hemodialysisPalmer, Suetonia C., Ruospo, Marinella, Wong, Germaine, Craig, Jonathan C., Petruzzi, Massimo, De Benedittis, Michele, Ford, Pauline, Johnson, David W., Tonelli, Marcello, Natale, Patrizia, Saglimbene, Valeria, Pellegrini, Fabio, Celia, Eduardo, Gelfman, Ruben, Leal, Miguel R., Torok, Marietta, Stroumza, Paul, Frantzen, Luc, Bednarek-Skublewska, Anna, Dulawa, Jan, Del Castillo, Domingo, Bernat, Amparo G., Hegbrant, Jorgen, Wollheim, Charlotta, Schon, Staffan, Gargano, Letizia, Bots, Casper P. and Strippoli, Giovanni F. M. (2016). Patterns of oral disease in adults with chronic kidney disease treated with hemodialysis. Nephrology Dialysis Transplantation, 31 (10), 1647-1653. doi: 10.1093/ndt/gfv413 |
|
2016 Journal Article Erythropoietin corrects anaemia and reduces the risk of blood transfusion in people with chronic kidney disease, but has uncertain effects on other patient-level outcomesJohnson, David W. (2016). Erythropoietin corrects anaemia and reduces the risk of blood transfusion in people with chronic kidney disease, but has uncertain effects on other patient-level outcomes. Evidence-Based Medicine, 21 (5), 178-178. doi: 10.1136/ebmed-2016-110418 |
|
2016 Journal Article The validity of left ventricular mass as a surrogate end point for all-cause and cardiovascular mortality outcomes in people With CKD: a systematic review and meta-analysisBadve, Sunil V., Palmer, Suetonia C., Strippoli, Giovanni F. M., Roberts, Matthew A., Teixeira-Pinto, Armando, Boudville, Neil, Cass, Alan, Hawley, Carmel M., Hiremath, Swapnil S., Pascoe, Elaine M., Perkovic, Vlado, Whalley, Gillian A., Craig, Jonathan C. and Johnson, David W. (2016). The validity of left ventricular mass as a surrogate end point for all-cause and cardiovascular mortality outcomes in people With CKD: a systematic review and meta-analysis. American Journal of Kidney Diseases, 68 (4), 554-563. doi: 10.1053/j.ajkd.2016.03.418 |
|
2016 Journal Article The role of cGMP and its signaling pathways in kidney diseaseShen, Kunyu, Johnson, David W. and Gobe, Glenda C. (2016). The role of cGMP and its signaling pathways in kidney disease. AJP - Renal Physiology, 311 (4), F671-F681. doi: 10.1152/ajprenal.00042.2016 |
|
2016 Journal Article Unconventional human T cells accumulate at the site of infection in response to microbial ligands and induce local tissue remodelingLiuzzi, Anna Rita, Kift-Morgan, Ann, Lopez-Anton, Melisa, Friberg, Ida M., Zhang, Jingjing, Brook, Amy C., Roberts, Gareth W., Donovan, Kieron L., Colmont, Chantal S., Toleman, Mark A., Bowen, Timothy, Johnson, David W., Topley, Nicholas, Moser, Bernhard, Fraser, Donald J. and Eberl, Matthias (2016). Unconventional human T cells accumulate at the site of infection in response to microbial ligands and induce local tissue remodeling. Journal of Immunology, 197 (6), 2195-2207. doi: 10.4049/jimmunol.1600990 |
|
2016 Journal Article Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor AlogliptinWhite, William B., Wilson, Craig A., Bakris, George L., Bergenstal, Richard M., Cannon, Christopher P., Cushman, William C., Heller, Simon K., Mehta, Cyrus R., Nissen, Steven E., Zannad, Faiez, Kupfer, Stuart, Aiub, Jorge, Albisu, Juan, Alvarez, Carlos, Astesiano, Alfredo, Barcudi, Raul, Bendersky, Mario, Bono, Julio, Bustos, Betina, Cartasegna, Luis, Caruso, Orlando, Casabe, Horacio, Castro, Remo, Colombo, Hugo, Cuneo, Carlos, Cura, Fernando, De Loredo, Luis, Dran, Ricardo, Fernandez, Horacio ... Zebrack, James (2016). Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin. Hypertension, 68 (3), 606-+. doi: 10.1161/HYPERTENSIONAHA.116.07797 |
|
2016 Journal Article Continuous quality improvement initiatives to sustainably reduce peritoneal dialysis-related infections in Australia and New ZealandNataatmadja, Melissa, Cho, Yeoungjee and Johnson, David W. (2016). Continuous quality improvement initiatives to sustainably reduce peritoneal dialysis-related infections in Australia and New Zealand. Peritoneal Dialysis International, 36 (5), 472-477. doi: 10.3747/pdi.2016.00114 |
|
2016 Journal Article Patient and caregiver priorities for outcomes in hemodialysis: an international nominal group technique studyUrquhart-Secord, Rachel, Craig, Jonathan C., Hemmelgarn, Brenda, Tam-Tham, Helen, Manns, Braden, Howell, Martin, Polkinghorne, Kevan R., Kerr, Peter G., Harris, David C., Thompson, Stephanie, Schick-Makaroff, Kara, Wheeler, David C., van Biesen, Wim, Winkelmayer, Wolfgang C., Johnson, David W., Howard, Kirsten, Evangelidis, Nicole and Tong, Allison (2016). Patient and caregiver priorities for outcomes in hemodialysis: an international nominal group technique study. American Journal of Kidney Diseases, 68 (3), 444-454. doi: 10.1053/j.ajkd.2016.02.037 |
|
2016 Journal Article Predictors of transfer to home hemodialysis after peritoneal dialysis completionNadeau-Fredette, Annie-Claire, Hawley, Carmel, Pascoe, Elaine, Chan, Christopher T., Leblanc, Martine, Clayton, Philip A., Polkinghorne, Kevan R., Boudville, Neil and Johnson, David W. (2016). Predictors of transfer to home hemodialysis after peritoneal dialysis completion. Peritoneal Dialysis International, 36 (5), 547-554. doi: 10.3747/pdi.2015.00121 |
|
2016 Journal Article Center-specific factors associated with peritonitis risk—a multi-center registry analysisNadeau-Fredette, Annie-Claire, Johnson, David W., Hawley, Carmel M., Pascoe, Elaine M., Cho, Yeoungjee, Clayton, Philip A., Borlace, Monique, Badve, Sunil V., Sud, Kamal, Boudville, Neil and McDonald, Stephen P. (2016). Center-specific factors associated with peritonitis risk—a multi-center registry analysis. Peritoneal Dialysis International, 36 (5), 509-518. doi: 10.3747/pdi.2015.00146 |
|
2016 Journal Article Ispd peritonitis tecommendations: 2016 update on prevention and treatmentLi, Philip Kam-Tao, Szeto, Cheuk Chun, Piraino, Beth, de Arteaga, Javier, Fan, Stanley, Figueiredo, Ana E., Fish, Douglas N., Goffin, Eric, Kim, Yong-Lim, Salzer, William, Struijk, Dirk G., Teitelbaum, Isaac and Johnson, David W. (2016). Ispd peritonitis tecommendations: 2016 update on prevention and treatment. Peritoneal Dialysis International, 36 (5), 481-508. doi: 10.3747/pdi.2016.00078 |
|
2016 Journal Article Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes a meta-analysisPalmer, Suetonia C., Mavridis, Dimitris, Nicolucci, Antonio, Johnson, David W., Tonelli, Marcello, Craig, Jonathan C., Maggo, Jasjot, Gray, Vanessa, De Berardis, Giorgia, Ruospo, Marinella, Natale, Patrizia, Saglimbene, Valeria, Badve, Sunil V., Cho, Yeoungjee, Nadeau-Fredette, Annie-Claire, Burke, Michael, Faruque, Labib, Lloyd, Anita, Ahmad, Nasreen, Liu, Yuanchen, Tiv, Sophanny, Wiebe, Natasha and Strippoli, Giovanni F. M. (2016). Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes a meta-analysis. JAMA: The Journal of the American Medical Association, 316 (3), 313-324. doi: 10.1001/jama.2016.9400 |
